StreetInsider.com News Articles

DSS, Inc. receives $500,000 loan from related party Alset Inc.

Mon, 21 Sep 2026 16:08:25 -0400

DSS, Inc. (NYSE: DSS) entered into a securities purchase agreement with Alset Inc., a Texas corporation, on September 15, 2026, under which Alset loaned the company $500,000 in exchange for a convertible promissory note and warrants to purchase 8,000,000 shares of DSS common stock.

The note bears simple interest at 3% per annum and is payable upon demand. Alset may convert any outstanding principal and interest into DSS common stock at $0.50 per share, with a maturity date five years from issuance. The warrants carry an exercise price of $0.55 per share and expire on their fifth anniversary.

Stockholder approval is required

Form 8-K DSS, INC. For: Sep 15

Mon, 21 Sep 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260921/27085376.html

Zoar files Form F-4 for Impact Biomedical business combination

Wed, 16 Sep 2026 09:26:26 -0400

DSS, Inc. (NYSE American: DSS) announced that Zoar Limited has filed a Registration Statement on Form F-4 with the U.S. Securities and Exchange Commission in connection with a proposed business combination involving Impact Biomedical Inc. (NYSE American: IBO).

The Registration Statement includes a preliminary proxy statement from Impact Biomedical and a prospectus from Zoar relating to the proposed transaction. The filing remains subject to SEC review and has not been declared effective.

DSS, which holds a significant ownership stake in Impact Biomedical, said the filing marks a step toward completing the transaction. Jason Grady, Chief Executive Officer of DSS, said: "The filing

Zoar files Form F-4 for Impact Biomedical business combination

Wed, 16 Sep 2026 09:26:26 -0400

DSS, which holds a significant ownership stake in Impact Biomedical, said the filing marks a step toward completing the transaction. Jason Grady, Chief Executive Officer of DSS, said: "The filing

DSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical’s Proposed Business Combination with Zoar Limited

Wed, 16 Sep 2026 09:25:00 -0400

ROCHESTER, N.Y., Sept. 16, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) (“DSS” or the “Company”) today announced that Zoar Limited (“Zoar” or “PubCo”) has filed a Registration Statement on Form F-4 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (“SEC”) in connection with the previously announced proposed business combination (the “Business Combination”) involving Impact Biomedical Inc. (NYSE American: IBO) (“Impact”), Zoar and certain related parties.

DSS is a significant stockholder of Impact Biomedical, and the filing represents an important step in Impact’s proposed Business Combination with Zoar.

“We are pleased to

DSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical’s Proposed Business Combination with Zoar Limited

Wed, 16 Sep 2026 09:25:00 -0400

ROCHESTER, N.Y., Sept. 16, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) (“DSS” or the “Company”) today announced that Zoar Limited (“Zoar” or “PubCo”) has filed a Registration Statement on Form F-4 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (“SEC”) in connection with the previously announced proposed business combination (the “Business Combination”) involving Impact Biomedical Inc. (NYSE American: IBO) (“Impact”), Zoar and certain related parties.

DSS is a significant stockholder of Impact Biomedical, and the filing represents an important step in Impact’s proposed Business Combination with Zoar.

“We are pleased to

DSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical’s Proposed Business Combination with Zoar Limited

Wed, 16 Sep 2026 09:25:00 -0400

ROCHESTER, N.Y., Sept. 16, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) (“DSS” or the “Company”) today announced that Zoar Limited (“Zoar” or “PubCo”) has filed a Registration Statement on Form F-4 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (“SEC”) in connection with the previously announced proposed business combination (the “Business Combination”) involving Impact Biomedical Inc. (NYSE American: IBO) (“Impact”), Zoar and certain related parties.

DSS is a significant stockholder of Impact Biomedical, and the filing represents an important step in Impact’s proposed Business Combination with Zoar.

“We are pleased to

DSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical’s Proposed Business Combination with Zoar Limited

Wed, 16 Sep 2026 09:25:00 -0400

ROCHESTER, N.Y., Sept. 16, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) (“DSS” or the “Company”) today announced that Zoar Limited (“Zoar” or “PubCo”) has filed a Registration Statement on Form F-4 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (“SEC”) in connection with the previously announced proposed business combination (the “Business Combination”) involving Impact Biomedical Inc. (NYSE American: IBO) (“Impact”), Zoar and certain related parties.

DSS is a significant stockholder of Impact Biomedical, and the filing represents an important step in Impact’s proposed Business Combination with Zoar.

“We are pleased to

Form SCHEDULE 13D/A DSS, INC. Filed by: Chan Heng Fai Ambrose

Tue, 08 Sep 2026 21:14:00 -0400
si-local-file:///var/storage/secattach/20260908/27037974.html

Form 4 DSS, INC. For: Sep 03 Filed by: Chan Heng Fai Ambrose

Tue, 08 Sep 2026 17:21:00 -0400
si-local-file:///var/storage/secattach/20260908/27037583.html

DSS, Inc. launches robotics subsidiary targeting enterprise automation

Tue, 08 Sep 2026 08:45:45 -0400

DSS, Inc. (NYSE American: DSS) announced the launch of DSS Robotics, a new business unit focused on AI-powered robotics and intelligent automation services for enterprise customers, according to a company press release dated Sept. 8, 2026.
The new subsidiary plans to offer services including strategic consulting, systems integration, deployment, lifecycle support and Robotics-as-a-Service (RaaS). DSS Robotics intends to work with technology partners to identify and deploy robotics and AI solutions tailored to customer operating environments.
As part of the initiative, DSS Robotics plans to establish an AI and Robotics Innovation Center at DSS Premier Packaging's manufacturing facility in Rochester, New York. The

DSS, Inc. Launches DSS Robotics to Bring AI-Powered Automation to Enterprise Operations

Tue, 08 Sep 2026 08:45:00 -0400

ROCHESTER, N.Y., Sept. 08, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a diversified technology company with experience in enterprise IT services, digital transformation, cybersecurity and authentication technologies, today announced the launch of DSS Robotics, a new business focused on AI-powered robotics and intelligent automation solutions for enterprise customers.

DSS Robotics expands the Company’s technology portfolio into artificial intelligence, robotics and intelligent automation, with a focus on helping organizations automate operational tasks, improve efficiency and support safer, more productive workplaces.

“Artificial intelligence and robotics are changing how businesses approach operations,” said Jason Grady, Chief Executive

DSS, Inc. Launches DSS Robotics to Bring AI-Powered Automation to Enterprise Operations

Tue, 08 Sep 2026 08:45:00 -0400

ROCHESTER, N.Y., Sept. 08, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a diversified technology company with experience in enterprise IT services, digital transformation, cybersecurity and authentication technologies, today announced the launch of DSS Robotics, a new business focused on AI-powered robotics and intelligent automation solutions for enterprise customers.

DSS Robotics expands the Company’s technology portfolio into artificial intelligence, robotics and intelligent automation, with a focus on helping organizations automate operational tasks, improve efficiency and support safer, more productive workplaces.

“Artificial intelligence and robotics are changing how businesses approach operations,” said Jason Grady, Chief Executive

DSS drops planned stock offering citing shelf registration limits

Fri, 04 Sep 2026 08:53:07 -0400

DSS, Inc. (NYSE American: DSS) announced it will not move forward with a previously announced public offering of common stock, citing limited capacity under its existing shelf registration statement.

The New York-based multinational company, which operates across product packaging, biotechnology, commercial lending, and securities and investment management, said it continues to evaluate alternative capital-raising options.

No additional details were provided regarding the size or timing of the original offering, or what alternatives the company may pursue.

DSS, Inc. Announces Decision Not to Proceed with Proposed Public Offering

Fri, 04 Sep 2026 08:53:00 -0400

NEW YORK, Sept. 04, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) (the “Company”), a multinational company operating across diverse industries including product packaging, biotechnology, commercial lending, and securities and investment management, today announced that after further consideration, the Company determined not to proceed with its previously announced proposed public offering of Common Stock due to the limited capacity available under its existing shelf registration statement.

The Company continues to evaluate its capital-raising alternatives and remains committed to creating value for shareholders. The Company’s Common Stock is traded on the NYSE American LLC under the symbol

DSS, Inc. Announces Decision Not to Proceed with Proposed Public Offering

Fri, 04 Sep 2026 08:53:00 -0400

NEW YORK, Sept. 04, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) (the “Company”), a multinational company operating across diverse industries including product packaging, biotechnology, commercial lending, and securities and investment management, today announced that after further consideration, the Company determined not to proceed with its previously announced proposed public offering of Common Stock due to the limited capacity available under its existing shelf registration statement.

The Company continues to evaluate its capital-raising alternatives and remains committed to creating value for shareholders. The Company’s Common Stock is traded on the NYSE American LLC under the symbol

Form 424B5 DSS, INC.

Fri, 04 Sep 2026 06:05:00 -0400
si-local-file:///var/storage/secattach/20260904/27027356.html

DSS, Inc. launches public stock offering on NYSE American

Thu, 03 Sep 2026 20:18:00 -0400

DSS, Inc. (NYSE American: DSS) announced the launch of a public offering of shares of its common stock, with proceeds intended for general corporate and working capital needs.

Aegis Capital Corp. is acting as sole book-running manager for the offering on a firm commitment basis. The offering is being made under an effective shelf registration statement on Form S-3 previously filed with the U.S. Securities and Exchange Commission and declared effective on Nov. 5, 2024.

The company said the offering is subject to market conditions and provided no assurance as to whether or when it may be completed, or as to its

DSS, Inc. Announces Launch of Proposed Public Offering

Thu, 03 Sep 2026 20:17:00 -0400

NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE: DSS) (the “Company”), a multinational company operating across diverse industries including product packaging, biotechnology, commercial lending, and securities and investment management, today announced that it has commenced a public offering to offer and sell shares of its Common Stock.

All of the shares of Common Stock are being offered by the Company (the “Offering”).

The Company intends to use the net proceeds from the Offering for general corporate and working capital needs. The Company’s Common Stock is trading on the NYSE American

DSS, Inc. Announces Launch of Proposed Public Offering

Thu, 03 Sep 2026 20:17:00 -0400

NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE: DSS) (the “Company”), a multinational company operating across diverse industries including product packaging, biotechnology, commercial lending, and securities and investment management, today announced that it has commenced a public offering to offer and sell shares of its Common Stock.

All of the shares of Common Stock are being offered by the Company (the “Offering”).

The Company intends to use the net proceeds from the Offering for general corporate and working capital needs. The Company’s Common Stock is trading on the NYSE American

American Fusion Inc. (OTC: AMFN) Appoints Asian Financial Markets and Digital Assets Executive Samson Lee as Independent Director

Mon, 17 Aug 2026 08:30:00 -0400

Coinstreet Group Founder and Veteran Hong Kong Financial Executive Brings More Than 25 Years of Capital Markets, Public Company, Strategic Partnership, International Finance, Commercialization and Emerging Technology Leadership Experience to American Fusion.

Lee to Help Support Board Governance, Strategic Partnerships and International Growth Initiatives

SOUTHLAKE, Texas, Aug. 17, 2026 (GLOBE NEWSWIRE) -- American Fusion Inc. (OTC: AMFN) (“American Fusion” or the “Company”), developer of the proprietary Texatron™ Fusion Engine™, today announced the appointment of Samson Lee to the Company’s Board of Directors as an Independent Director, adding one of Asia’s most experienced digital-finance, capital-markets

American Fusion Inc. (OTC: AMFN) Appoints Asian Financial Markets and Digital Assets Executive Samson Lee as Independent Director

Mon, 17 Aug 2026 08:30:00 -0400

Coinstreet Group Founder and Veteran Hong Kong Financial Executive Brings More Than 25 Years of Capital Markets, Public Company, Strategic Partnership, International Finance, Commercialization and Emerging Technology Leadership Experience to American Fusion.

Lee to Help Support Board Governance, Strategic Partnerships and International Growth Initiatives

SOUTHLAKE, Texas, Aug. 17, 2026 (GLOBE NEWSWIRE) -- American Fusion Inc. (OTC: AMFN) (“American Fusion” or the “Company”), developer of the proprietary Texatron™ Fusion Engine™, today announced the appointment of Samson Lee to the Company’s Board of Directors as an Independent Director, adding one of Asia’s most experienced digital-finance, capital-markets

American Fusion Inc. (OTC: AMFN) Appoints Asian Financial Markets and Digital Assets Executive Samson Lee as Independent Director

Mon, 17 Aug 2026 08:30:00 -0400

Coinstreet Group Founder and Veteran Hong Kong Financial Executive Brings More Than 25 Years of Capital Markets, Public Company, Strategic Partnership, International Finance, Commercialization and Emerging Technology Leadership Experience to American Fusion.

Lee to Help Support Board Governance, Strategic Partnerships and International Growth Initiatives

SOUTHLAKE, Texas, Aug. 17, 2026 (GLOBE NEWSWIRE) -- American Fusion Inc. (OTC: AMFN) (“American Fusion” or the “Company”), developer of the proprietary Texatron™ Fusion Engine™, today announced the appointment of Samson Lee to the Company’s Board of Directors as an Independent Director, adding one of Asia’s most experienced digital-finance, capital-markets

American Fusion Inc. (OTC: AMFN) Appoints Asian Financial Markets and Digital Assets Executive Samson Lee as Independent Director

Mon, 17 Aug 2026 08:30:00 -0400

Coinstreet Group Founder and Veteran Hong Kong Financial Executive Brings More Than 25 Years of Capital Markets, Public Company, Strategic Partnership, International Finance, Commercialization and Emerging Technology Leadership Experience to American Fusion.

Lee to Help Support Board Governance, Strategic Partnerships and International Growth Initiatives

SOUTHLAKE, Texas, Aug. 17, 2026 (GLOBE NEWSWIRE) -- American Fusion Inc. (OTC: AMFN) (“American Fusion” or the “Company”), developer of the proprietary Texatron™ Fusion Engine™, today announced the appointment of Samson Lee to the Company’s Board of Directors as an Independent Director, adding one of Asia’s most experienced digital-finance, capital-markets

American Fusion Inc. (OTC: AMFN) Appoints Asian Financial Markets and Digital Assets Executive Samson Lee as Independent Director

Mon, 17 Aug 2026 08:30:00 -0400

Coinstreet Group Founder and Veteran Hong Kong Financial Executive Brings More Than 25 Years of Capital Markets, Public Company, Strategic Partnership, International Finance, Commercialization and Emerging Technology Leadership Experience to American Fusion.

Lee to Help Support Board Governance, Strategic Partnerships and International Growth Initiatives

SOUTHLAKE, Texas, Aug. 17, 2026 (GLOBE NEWSWIRE) -- American Fusion Inc. (OTC: AMFN) (“American Fusion” or the “Company”), developer of the proprietary Texatron™ Fusion Engine™, today announced the appointment of Samson Lee to the Company’s Board of Directors as an Independent Director, adding one of Asia’s most experienced digital-finance, capital-markets